Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance-Reference-Cited by-同舟云学术

Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance

Published:2005-02 Issue:2 Volume:47 Page:183-192
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Bepler Gerold,Zheng Zhong,Gautam Ashish,Sharma Swati,Cantor Alan,Sharma Anupama,Cress W. Douglas,Kim Young-Chul,Rosell Rafael,McBride Colleen,Robinson Lary,Sommers Eric,Haura Eric

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference15 articles.

1. Ribonucleotide reductase: regulation, regulation, regulation;Elledge;Trends Biochem. Sci.,1992

2. Mouse ribonucleotide reducatse: from genes to proteins;Filatov;Biochem. Soc. Trans.,1995

3. Ribonucleotide reductases in the twenty-first century;Stubbe;Proc. Natl. Acad. Sci. U.S.A.,1998

4. Cell cycle-dependent expression of mammalian ribonucleotide reductase;Engstroem;J. Biol. Chem.,1985

5. Ribonucleotide reductase M1 subunit in cellular proliferation, quiescence, and differentiation;Mann;Cancer Res.,1988

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic polymorphisms and platinum-induced hematological toxicity: a systematic review;Frontiers in Pharmacology;2024-08-21

2. Genetic polymorphisms as potential pharmacogenetic biomarkers for platinum-based chemotherapy in non-small cell lung cancer;Molecular Biology Reports;2024-01-13

3. Acquired chemoresistance drives spatial heterogeneity, chemoprotection and collective migration in pancreatic tumor spheroids;PLOS ONE;2022-05-26

4. Gene‐Gene Interactions of Gemcitabine Metabolizing‐Enzyme Genes hCNT3 and WEE1 for Preventing Severe Gemcitabine‐Induced Hematological Toxicity;The Journal of Clinical Pharmacology;2021-06-10

5. The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells;Pharmaceuticals;2019-09-02